How the 2025 Expert Consensus and MENO‑ABC Trial Challenge Old Rules Takeaways The 2025 expert consensus opens the door to case-by-case HRT use in low-risk breast cancer survivors. Vaginal estrogen therapy shows minimal…
Takeaways FGF21 and GDF15 analogs offer distinct mechanisms beyond GLP-1 for treating obesity and metabolic disease. Late-stage trials show promising effects on liver fat, appetite control, and thermogenesis with fewer GI side effects.…